Chronic Inflammation in Scarring Alopecia May Heighten Skin Cancer Risk, Review Finds Medha Baranwal20 May 2025 8:15 PM ISTUSA: A recent literature review published in Skin Appendage Disorders has raised concerns about a possible link between primary scarring alopecia and...
AstraZeneca successfully completes acquisition of EsoBiotec Ruchika Sharma20 May 2025 12:27 PM ISTAstraZeneca has successfully completed the acquisition of EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated...
Pfizer strikes cancer drug deal with China's 3SBio Ruchika Sharma20 May 2025 11:30 AM IST3SBio plans to initiate the first Phase 3 study in China in 2025.
Study reveals surprising side effects of high-dose radiation therapy Dr. Kamal Kant Kohli19 May 2025 8:15 PM ISTIn a new study published in Nature, researchers at the University of Chicago Medicine Comprehensive Cancer Center explore a surprising phenomenon in...
Blood group type A identified as potential breast cancer risk factor, reveals research Dr. Kamal Kant Kohli18 May 2025 9:00 PM ISTA new review paper was published in Volume 16 of Oncotarget on May 9, 2025, titled "Relationship between ABO blood group antigens and Rh factor with...
Cervical Cancer Screening: Vaginal Self-Sampling Outshines Urine in Accuracy, Study Finds Medha Baranwal16 May 2025 8:45 PM ISTChina: A recent meta-analysis published in the International Journal of Gynecology & Obstetrics has found that both vaginal and urine...
AACR: Topical treatment offers relief from painful skin rash caused by targeted cancer therapy Dr. Kamal Kant Kohli16 May 2025 8:45 PM ISTResearchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a...
Minimally Invasive Hepatectomy Shows Superior Survival in Early to Intermediate HCC: Study Jacinthlyn Sylvia16 May 2025 8:30 PM ISTA new study published in the Journal of Hepatocellular Carcinoma showed that minimally invasive hepatectomy (MIH) offers better overall survival...
FDA Expands Approval of Belzutifan for Treatment of pheochromocytoma or paraganglioma Dr. Kamal Kant Kohli16 May 2025 7:45 AM ISTThe US food and Drug Administration (FDA) has expanded the approval of Belzutifan (Welireg) to treat specific types of pheochromocytoma or...
Probiotic supplementation may help reduce chemotherapy side effects in breast cancer, finds study Dr. Kamal Kant Kohli15 May 2025 8:15 PM ISTChemotherapy is one of the most popular ways to treat breast cancer. Even though it has proven to be effective. it also has downsides, such as a...
Merck scores USFDA OK for Welireg for 12 years and older with pheochromocytoma or paraganglioma Ruchika Sharma15 May 2025 11:45 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has received the approval from the U.S. Food and Drug Administration...
More men with prostate cancer are avoiding unnecessary surgery, reveals JAMA study Dr. Kamal Kant Kohli14 May 2025 9:00 PM ISTProstate cancer is a leading cause of cancer-related death among men in the United States. Despite this, widespread adoption of prostate cancer...
